Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05106959 · ClinicalTrials.gov registry record · NA

Piloting a Motivational Interviewing Shame-Resilience Training

A NA study, sponsored by University of New Mexico.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT05106959: Completed NA study, sponsored by University of New Mexico.

NCT05106959 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05106959, a NA study, has completed, sponsored by University of New Mexico.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the shame resilience theory in a pilot context to assess its feasibility in a potential full scale clinical trial. Shame resilience was developed through qualitative methods but currently has little quantitative backing. Continued research is needed to assess shame-resilience as a potential intervention for shame which little is known to combat prevalent negative health outcomes associated with shame.

Primary Outcome

This measure looks at participants willingness to communicate about their health on a 5 point Likert Scale; 1-5 with higher scores indicating a greater willingness to communicate. Participants respond to a series of questions on a questionnaire.

Interventions

  • BEHAVIORAL Motivational Interviewing Informed Shame Resilience Training

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-06-26
Est. Completion 2021-02-28
Phase NA
University of New Mexico

168 total trials

What the finished NCT05106959 record still lists

NCT05106959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Motivational Interviewing Informed Shame Resilience Training is the first listed.

NCT05106959 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05106959 about?

NCT05106959 is a clinical study titled "Piloting a Motivational Interviewing Shame-Resilience Training". The purpose of this study is to evaluate the shame resilience theory in a pilot context to assess its feasibility in a potential full scale clinical trial. Shame resilience was developed through qualitative methods but currently has little quantitative backing. Continued research is needed to assess...

What is the current status of trial NCT05106959?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-06-26. Estimated completion is 2021-02-28.

What interventions are being tested in trial NCT05106959?

The interventions under investigation include: Motivational Interviewing Informed Shame Resilience Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05106959?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05106959's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05106959, the US trial registry maintained by the National Library of Medicine. NCT05106959 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.